Appoints PENTAX Medical's Global Chief Clinical Officer, Dr. Hudson Garrett Jr., to Their Global Advisory Board

September 14, 2016

MONTVALE, NJ -- September 14, 2016 - PENTAX Medical Corp. (PENTAX Medical), a healthcare industry leader in endoscopic imaging, announced today that Dr. Hudson Garrett Jr. has been selected as one of thirteen global experts to be invited to join the Global Advisory Board. is a global entity committed to publishing high quality, peer-reviewed research articles and perspective pieces that are focused on the topics of infection control and prevention.

"I am very excited to have the continued opportunity to work closely with on pertinent infection prevention and control issues related to patient safety, healthcare quality, and improvement of clinical outcomes internationally," said Dr. Garrett. "I am committed to advancing evidence-based practice in the field of infection prevention and control and addressing critical elements of patient safety such as medical device hygiene and environmental decontamination."

To learn more about the Global Advisory Board, please visit:

About PENTAX Medical
PENTAX Medical is a division of HOYA Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe. PENTAX Medical employees represent the diverse countries where we do business, allowing us to provide innovative solutions tailored to meet local needs.

Press Contact:
Mariano Franco
Associate Director of Marketing Communications P
ENTAX Medical, Americas

T: 1.800.750.5558 ext. 244